ArticleCancers2018

DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer.

Ravikiran Mahadevappa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.